Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D03RCB
|
|||
| Former ID |
DIB012170
|
|||
| Drug Name |
FGI-101-1A6
|
|||
| Synonyms |
FGI-101; Anti-tumor susceptibility gene protein 101 mAb (viral infection), Functional Genetics; Anti-TSG101 monoclonal antibody (viral infection/prostate cancer), Functional Genetics
Click to Show/Hide
|
|||
| Drug Type |
Antibody
|
|||
| Indication | Influenza virus infection [ICD-11: 1E30-1E32] | Phase 1 | [1] | |
| Company |
Functional genetics
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Tumor susceptibility gene protein 101 (TSG101) | Target Info | . | [1] |
| KEGG Pathway | Endocytosis | |||
| Pathway Interaction Database | Glucocorticoid receptor regulatory network | |||
| Internalization of ErbB1 | ||||
| Reactome | Budding and maturation of HIV virion | |||
| Membrane binding and targetting of GAG proteins | ||||
| WikiPathways | HIV Life Cycle | |||
| Membrane Trafficking | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01299142) Safety and Pharmacokinetics Study of Human Monoclonal Antibody (FGI-101-1A6). U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.